Accutane aftercare instructions: Free template and use guide

Key takeaways

Isotretinoin causes prolonged skin dryness and sensitivity; proper aftercare protects clear skin results and prevents complications.

Patients must continue strict sun protection (SPF 30+) and avoid waxing, lasers, and cosmetic procedures for at least 6 months post-treatment due to skin fragility.

Female patients of childbearing age must continue contraception for one month after stopping isotretinoin to comply with IPLEDGE (US) and the NHS Pregnancy Prevention Programme (UK).

A practice-branded aftercare handout keeps patient messaging consistent across every clinician on your dermatology team.

Patients who finish an isotretinoin course often assume their acne is resolved and that their care responsibility ends at the final appointment. Without written aftercare guidance, that assumption leads to avoidable problems: acne rebound, sunburn from unprotected skin, or a lapse in the contraception window that IPLEDGE and the NHS Pregnancy Prevention Programme both require.

This guide covers what Pabau’s downloadable Accutane aftercare instructions sheet contains, how to use it at the end-of-course appointment, and why handing patients a written copy matters more than verbal advice alone.

What is an Accutane aftercare instructions template?

Accutane aftercare instructions are guidance sheets that dermatology practices give patients immediately after their final isotretinoin dose, distinct from the acne treatment consent paperwork signed at the start of the course. Isotretinoin’s effects on skin and contraception requirements persist well past the last pill, so patients need clear, written direction rather than a verbal recap on their way out the door.

The template covers three clinical pillars: skin barrier repair (dryness persists 4-8 weeks post-course), sun sensitivity protection (isotretinoin increases photosensitivity), and contraception awareness (a reminder that IPLEDGE in the US and the NHS Pregnancy Prevention Programme in the UK both require patients to continue contraception for one month after the final dose).

The handout is a plain-language instruction sheet rather than a structured form. It ends with a single line for the patient to confirm they have read and understood the information and had the chance to ask questions.

A practice-branded version, distributed through a digital intake forms system, still ensures every patient receives the same messaging and that your practice has a record of that acknowledgment.

How to use this template in your practice

Distribute the sheet as a printed handout at the final isotretinoin appointment, or as a digital document through your patient portal alongside follow-up communication. Practices already running on dermatology practice management software can build this handout directly into that workflow. Five steps help practice teams work it into the end-of-course visit:

1. Customize practice details at the top – insert your practice name, address, contact number, and the prescribing dermatologist’s details so patients know who to contact if complications arise.
2. Walk through the During Treatment and First Few Weeks sections with the patient – read through hydration, gentle skincare, and sun protection guidance aloud before the patient leaves, rather than relying on them to read it unassisted at home.
3. Review the skincare protocol section – confirm the post-treatment routine aligns with your practice’s standard aftercare products (cleanser brand, moisturizer preference, SPF type) so you can reference stock items patients may purchase or receive from your practice.
4. Reinforce the contraception requirement in the Duration of Treatment section – the sheet instructs patients to use two forms of contraception and follow their doctor’s guidance on pregnancy testing; confirm verbally that the patient understands this, since the handout itself does not include a dedicated contraception sign-off – track that acknowledgment separately in your practice’s consent records.
5. Have the patient sign the confirmation line – the template ends with a single statement confirming the patient has read and understood the information and had the chance to ask questions. Get that signature before the patient leaves and file the signed copy in their record.

When to give patients this template

Distribute this template at the final isotretinoin appointment, immediately after the last dose. Do not delay – patients often assume the appointment ends their care responsibility, and a verbal reminder to “keep your skin moisturized” does not carry the same weight as a signed, practice-branded aftercare document (the same principle applies to other post-procedure handouts, such as cyst removal aftercare instructions).

The sheet serves practices in three scenarios:

• End-of-course handoff: Patient has completed the full isotretinoin course (typically 15-20 weeks) and is stopping the medication. Provide this template along with clear instructions on monitoring for rebound acne or adverse effects.
• Regulatory documentation: In IPLEDGE programs (US) and the NHS Pregnancy Prevention Programme (UK), aftercare instruction sheets serve as evidence that the practice provided post-treatment safety guidance. Retain signed copies in the patient record to satisfy audits.
• Referral handover: If a patient will receive ongoing dermatology care from another practice, pair this template with a completed medical referral form to ensure continuity of aftercare messaging and prevent conflicting advice about sun protection timing, retinoid reintroduction, or follow-up appointments.

Timing sensitivity: Isotretinoin side effects (dryness, lip peeling, eye irritation) can persist for 2-4 weeks after the final dose. The first 48 hours post-completion are critical. Provide this template before the patient leaves on treatment-completion day, so they begin the aftercare protocol immediately rather than waiting days and developing preventable complications.

Skincare routine after Accutane

The post-Accutane skincare window (Weeks 1-4) prioritizes barrier repair over active treatment, following the same barrier-first principles found in most post-procedure aftercare guidelines. Patients’ skin is denuded of sebaceous gland function, which isotretinoin suppresses semi-permanently, and is prone to irritation from previously tolerated products. The sheet recommends:

• Gentle, non-comedogenic cleansers – avoid sulfates, physical scrubs, and astringent products. Recommend a milk or oil cleanser to preserve the weakened skin barrier.
• Heavy moisturizer (cream or ointment base) – hyaluronic acid serums under a ceramide-rich moisturizer help rehydrate. Occlusive products (petroleum jelly, aquaphor) on lips and extremely dry patches are normal post-treatment.
• SPF 30-50 daily, even indoors – isotretinoin increases photosensitivity for weeks to months post-course. SPF should be non-comedogenic and reapplied every 2 hours if outdoors.
• Avoid active ingredients for 4-8 weeks – retinoids (tretinoin, retinol, adapalene), AHAs, BHAs, and vitamin C serums should be withheld initially. When patients ask when they can restart active skincare, the sheet’s guidance is to consult the dermatologist at the follow-up visit rather than commit to a fixed date, since tolerance varies.

Contraception continuation for female patients

This is the highest regulatory priority. Isotretinoin is a Category X teratogen, and pregnancy during or shortly after treatment causes severe birth defects. The IPLEDGE program (US FDA) and the NHS Pregnancy Prevention Programme (UK, administered by MHRA) both require female patients of childbearing age to continue contraception for one month after the final isotretinoin dose.

The aftercare sheet states this requirement in plain language, but it does not include a dedicated contraception checkbox or signature section – the single confirmation line at the end covers the whole document.

If your practice needs a signature-level record of contraception method and start date, capture that separately through your consent or intake paperwork rather than relying on the aftercare handout itself.

Store that separate contraception documentation in your regulatory compliance files. During CQC inspections (UK) or internal compliance reviews (US), these records demonstrate that your practice provided evidence-based post-treatment safety guidance to female patients.

Key warnings and monitoring

The sheet lists five warning signs that should prompt patients to contact the practice urgently post-treatment:

• Persistent severe dryness or redness unresponsive to moisturizer – suggests inadequate barrier repair; may warrant prescription emollients or topical corticosteroids if post-inflammatory erythema develops.
• Unexpected acne flare after initial clearance – around 20% of patients experience acne recurrence within 6-12 months; early flares (within 2 weeks) may signal incomplete dosing or patient non-compliance during the course. Early intervention with a second course or alternative therapy works better than waiting.
• Signs of infection or pustulation in treated areas – isotretinoin causes mild immunosuppression, so secondary bacterial infection of residual acne lesions requires antibiotics.
• Eye symptoms (dry eye, photophobia, corneal abrasion) – meibomian gland suppression is semi-permanent; severe dry eye persisting beyond Week 4 warrants ophthalmology referral and artificial tears prescription.
• Mental health changes (mood swings, depression, suicidal ideation) – isotretinoin’s psychiatric risk persists post-treatment in some patients. Patients should report mood changes immediately, and the practice should have mental health crisis contact information ready to share (national helpline, local emergency, psychiatry support).

Add your practice’s own contact protocols alongside the template: a phone number for routine questions, an email for non-urgent aftercare queries, and an emergency contact (on-call dermatologist, after-hours line) so patients know their escalation options rather than waiting for the next scheduled follow-up.

When to schedule follow-up appointments

Structured post-treatment follow-up appointments prevent complications and demonstrate clinical diligence. The aftercare sheet itself does not include appointment-date fields, so use your practice’s own intake and scheduling system to book these visits at the final treatment appointment, at intervals aligned with isotretinoin safety guidance:

• Week 2 post-treatment: Assess skin barrier recovery, confirm contraception compliance (if applicable), address early dryness or sensitivity, and review the skincare routine for adjustments.
• Week 4-6 post-treatment: Evaluate for delayed adverse effects (persistent eye dryness, acne rebound, mood changes). Discuss timing for reintroducing active skincare ingredients – most dermatologists recommend 6-8 weeks minimum before low-strength retinoids.
• Month 3 post-treatment: Assess long-term outcome (acne remains clear, dryness resolved, no recurrence signs) and plan any adjunctive treatments (maintenance topicals, chemical peels for scarring, follow-up prescriptions for lipid or liver function monitoring if initially abnormal).

Pre-book these visits before the patient leaves the final treatment appointment to reduce friction and improve attendance. Use your practice’s online booking system to send automated appointment reminders one week before each follow-up. This improves compliance and reduces no-shows during the critical post-treatment window.

Benefits of using an aftercare instructions template

A practice-branded, paperless aftercare documentation process provides measurable advantages:

• Regulatory compliance. Signed aftercare sheets serve as evidence that your practice provided post-treatment safety guidance to patients, supporting IPLEDGE audits, NHS PPP requirements, and CQC inspection standards.
• Reduced liability. If a patient later claims they weren’t informed about sun protection timing or contraception requirements, a signed template proves otherwise. Documentation is your best defense.
• Consistency across practitioners. Multiple dermatologists in your practice may give slightly different verbal aftercare advice. A standard template ensures all patients receive the same core messaging regardless of which clinician performs their final appointment.
• Streamlined handoff. Rather than spending 10 minutes explaining aftercare verbally, hand over the template, review the key sections together, and let the document serve as the reference guide at home.
• Improved patient outcomes. Patients with clear written instructions follow aftercare protocols more reliably than those relying on memory. Better compliance reduces acne recurrence, secondary infections, and preventable complications.

Store the signed handout using clinical documentation software and a secure HIPAA-compliant patient data management system, so your team can retrieve it for audits and print copies on demand without digging through paper files.

Book a demo to see how Pabau’s digital forms and patient portal streamline aftercare documentation delivery and compliance tracking for dermatology practices.

Key points for practice teams

Patients completing isotretinoin have invested months in treatment. Inadequate aftercare guidance can undo those gains through acne recurrence, procedural injuries from premature waxing or laser treatment, or a lapse in contraception shortly after stopping the medication.

Give every patient a practice-branded aftercare instructions sheet and build it into your standard end-of-course workflow. Patients retain written guidance far better than verbal counseling, and the signed document gives your practice a record that supports liability protection and regulatory inspections.

Expert picks

Continue your research

Need to bill accurately for other equipment or procedures your practice provides? HCPCS Code L1845: Knee orthosis double upright billing guide covers the documentation requirements that keep orthotics claims clean and reduce denials.

Screening for behavioral health alongside dermatology care? Internet Addiction Test is a free downloadable screening template practices use to flag patients who may benefit from a referral.

Supporting patients managing other chronic conditions? Eating disorder worksheets for recovery give your practice a structured, printable resource for recovery-focused sessions.

Frequently Asked Questions